Scientists
Researchers at the University of Dundee in Scotland have developed a novel mathematical modeling approach to study the role of Aurora kinases in cancer therapy. The pharmacodynamic model, presented in a recent report, aims to overcome the difficulty of linking inhibitor concentration and efficacy using standard methods. By encapsulating the
Scientists
According to recent research in the United States, the availability of safe and effective monoclonal antibodies has revolutionized the treatment of B-cell malignancies. The addition of rituximab to standard chemotherapy regimens has significantly prolonged the survival of patients with diffuse large B-cell lymphoma (DLBCL) and follicular non-Hodgkin lymphoma. However, despite
Cancer research
Scientists from Wuhan, People's Republic of China, have made significant progress in the field of cancer gene therapy by exploring the use of Apoptin, a protein derived from a chicken anemia virus. The study, published in the International Journal of Cancer, reveals that a recombinant pseudotype baculovirus expressing
Cancer
Researchers at the University of Tokyo's Institute of Medical Science have made a significant discovery regarding the role of WD repeat and high-mobility group box DNA binding protein 1 (WDHD1) in lung and esophageal cancer. The study, published in Clinical Cancer Research, aimed to identify novel biomarkers and
Cancer
A team of researchers from Shanghai, People's Republic of China, has made a significant breakthrough in cancer gene therapy using a novel approach that involves targeting tumor cells with nanoscale polymer micelles. According to the study published in Biomaterials, the researchers developed a method to create anti-HIF-1alpha antibody-conjugated
Cancer
Researchers have made a significant discovery in the treatment of melanoma, a type of skin cancer, by identifying key characteristics of promoter regions that define susceptibility to the epigenetic agent decitabine. In a study published in the journal BMC Medical Genomics, J.C. Rubinstein and colleagues from Yale University found
Cancer
Scientists in the United States have successfully engineered gold nanorods with enhanced photothermal stability and gene delivery efficacy using polyelectrolytes. The investigators found that chemically generated gold nanorods rapidly aggregate in biologically relevant media, hindering their effective use in biomedical applications. By depositing polyelectrolyte multilayers on gold nanorods, the researchers
Cancer
Scientists in the United Kingdom have made a groundbreaking discovery in the field of cancer research, developing a novel CHK1 inhibitor that has the potential to enhance antitumor activity with selected anticancer drugs in vivo. The study, led by M.I. Walton and colleagues at the Institute of Cancer Research,
Cancer
Gene therapy, a relatively new field of medicine, holds promise for treating thoracic malignancies, including mesothelioma and lung cancer, which are associated with a poor prognosis. Current treatment regimens have not been effective in halting the progressive course of these diseases. Researchers at the University of Pennsylvania have been evaluating
Cancer
Gonadotropin hormones, specifically Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH), have been shown to stimulate the migration and proliferation of ovarian cancer cells. Australian researchers, led by I. Mertens-Walker from the University of Sydney, Kolling Institute of Medical Research, conducted an in-depth study on the effects of gonadotropins on ovarian
Cancer
Researchers at Philipps University in Marburg, Germany, have discovered that polyethylenimine (PEI) complexes with small interfering RNA (siRNA) can exert anti-tumor effects synergistically with the monoclonal anti-vascular endothelial growth factor (VEGF) antibody Bevacizumab. The study, published in the Journal of Gene Medicine - Gene Therapy Clinical Trial Database, investigated the
Cancer
Researchers have found new data on germ cell cancer in a recent study published in Pathology, Research and Practice. The study investigated the loss of heterozygosity (LOH) of four tumor suppressor genes in testicular germ cell tumors (TGCTs). The researchers analyzed 38 TGCTs, including 17 seminomas and 21 nonseminomas, and
